title: Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemia.
authors: Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
authors: Aleksandar
authors: A
authors: Radujkovic
authors: Peter
authors: P
authors: Dreger
authors: Ute
authors: U
authors: Hegenbart
authors: Eike C
authors: EC
authors: Buss
authors: Thomas
authors: T
authors: Luft
authors: Anthony D
authors: AD
authors: Ho
authors: Stefan
authors: S
authors: Fruehauf
authors: Julian
authors: J
authors: Topaly
mesh_terms: D001549:Benzamides / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000628:therapy*; D010879:Piperazines / Q000008:administration & dosage; D011743:Pyrimidines / Q000008:administration & dosage; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014916:Whole-Body Irradiation
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D003520:Cyclophosphamide